0001104659-21-095504.txt : 20210723
0001104659-21-095504.hdr.sgml : 20210723
20210723181017
ACCESSION NUMBER: 0001104659-21-095504
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210721
FILED AS OF DATE: 20210723
DATE AS OF CHANGE: 20210723
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Adair Jason
CENTRAL INDEX KEY: 0001747055
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39724
FILM NUMBER: 211111820
MAIL ADDRESS:
STREET 1: C/O LIQUIDIA TECHNOLOGIES, INC.
STREET 2: 419 DAVIS DRIVE, SUITE 100
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Liquidia Corp
CENTRAL INDEX KEY: 0001819576
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851710962
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: P.O. BOX 110085
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: 919.328.4400
MAIL ADDRESS:
STREET 1: P.O. BOX 110085
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
4
1
tm2123135-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-07-21
0
0001819576
Liquidia Corp
LQDA
0001747055
Adair Jason
419 DAVIS DRIVE, SUITE 100
MORRISVILLE
NC
27560
0
1
0
0
V.P. Crp Dvlpmnt and Strtgy
Stock Option (Right to Buy)
2.54
2021-07-21
4
A
0
10000
0
A
2031-07-21
Common Stock
10000
10000
D
The option vests over a four-year period with 25% of the shares of common stock underlying the option vesting on the one-year anniversary of the grant date and the remaining 75% of the shares of common stock underlying the option vesting in equal monthly installments thereafter, becoming fully vested on July 21, 2025; provided, however, that notwithstanding the foregoing vesting schedule, 50% of the shares of common sock underlying the option will vest upon U.S. Food and Drug Administration (FDA) tentative approval of the Issuer's New Drug Application for LIQ861.
/s/ Jason Adair
2021-07-23